滤泡性淋巴瘤血清单克隆蛋白的基线相关性与预后影响
单中心311例滤泡性淋巴瘤患者诊断时血清免疫固定电泳阳性者占26%,两组基线特征除年龄较大和β2微球蛋白升高比例较高外相近。中位随访4.6年,阳性与早期复发风险升高、无进展生存和总生存缩短相关;60岁以上患者中阳性为总生存的独立预测因素。
要点
- 约四分之一滤泡性淋巴瘤患者诊断时血清免疫固定电泳阳性。
- 阳性与早期复发风险升高及无进展生存、总生存缩短相关。
- 60岁以上患者中阳性是总生存的独立预测因素。
核心结论
- 约四分之一的滤泡性淋巴瘤患者诊断时血清免疫固定电泳阳性,且是不良预后的预测因素。
研究设计与样本
- 单中心回顾性研究,纳入311例诊断时具有血清免疫固定电泳信息的滤泡性淋巴瘤患者,比较阳性与阴性组的基线特征和结局。
主要发现
- 血清免疫固定电泳阳性82例(26%),两组基线特征可比,但阳性组年龄更大且β2微球蛋白升高比例更高。
临床怎么用
- 诊断时检测血清免疫固定电泳有助于识别高危滤泡性淋巴瘤患者,尤其是60岁以上人群。
局限性
- 单中心回顾性研究,样本量311例,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The presence of a serum monoclonal component has been associated with poor outcomes in some lymphomas. However, data in follicular lymphoma (FL) are scarce. We studied 311 FL patients diagnosed at a single institution, for whom information on serum immunofixation electrophoresis (sIFE) at diagnosis was available. Baseline characteristics and outcomes were compared between patients with a positive (+sIFE) and a negative sIFE (-sIFE). sIFE was positive in 82 patients (26%). Baseline features were comparable between both groups, except for an older age and higher proportion of elevated β2 -microglobulin levels in the +sIFE group. With a median follow-up of 4.6 years, a +sIFE was associated with a higher risk of early relapse (POD24, 27% vs. 15%, P = 0·02), shorter progression-free survival (PFS; 42% vs. 52% at 5 years, P = 0·008), and shorter overall survival (OS; 59% vs. 77% at 10 years, P = 0·046). In patients >60 years, a +sIFE was an independent predictor of OS [hazard ratio (HR) = 2·4, 95% confidence interval (CI): 1·2-5·0; P = 0·02]. Approximately one quarter of patients with FL has a +sIFE at diagnosis, which is a predictor of poor outcome. These findings encourage further investigation of its relationship with B-cell biology and the tumour microenvironment.
引用
- Mozas P, Rivero A, Rivas-Delgado A, et al. Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma. Br J Haematol. 2020. PMID: 33200406. doi:10.1111/bjh.17138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。